vs
LANDMARK BANCORP INC（LARK）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是LANDMARK BANCORP INC的1.9倍（$35.5M vs $18.8M），LANDMARK BANCORP INC净利率更高（27.0% vs -304.2%，领先331.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 14.0%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 13.1%）
Landmark Bancorp Inc是一家总部位于美国的银行控股公司，运营Landmark National Bank，主要服务美国堪萨斯州的社区客户，提供全方位个人及商业银行服务，包括存款账户、住房抵押贷款、商业贷款及财富管理方案，服务对象涵盖个人消费者与本地中小企业。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LARK vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.9倍
$18.8M
营收增速更快
RXRX
高出667.7%
14.0%
净利率更高
LARK
高出331.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
13.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $35.5M |
| 净利润 | $5.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 27.0% | -304.2% |
| 营收同比 | 14.0% | 681.7% |
| 净利润同比 | 7.8% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LARKRXRX
| Q1 26 | $18.8M | — | ||
| Q4 25 | $18.7M | $35.5M | ||
| Q3 25 | $18.2M | $5.2M | ||
| Q2 25 | $17.3M | $19.2M | ||
| Q1 25 | $16.5M | $14.7M | ||
| Q4 24 | $15.8M | $4.5M | ||
| Q3 24 | $15.9M | $26.1M | ||
| Q2 24 | $14.7M | $14.4M |
净利润LARKRXRX
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.7M | $-108.1M | ||
| Q3 25 | $4.9M | $-162.3M | ||
| Q2 25 | $4.4M | $-171.9M | ||
| Q1 25 | $4.7M | $-202.5M | ||
| Q4 24 | $3.3M | $-178.9M | ||
| Q3 24 | $3.9M | $-95.8M | ||
| Q2 24 | $3.0M | $-97.5M |
毛利率LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | 31.7% | -304.8% | ||
| Q3 25 | 33.4% | -3327.6% | ||
| Q2 25 | 30.9% | -916.8% | ||
| Q1 25 | 34.7% | -1297.9% | ||
| Q4 24 | 15.2% | -4042.4% | ||
| Q3 24 | 30.3% | -377.1% | ||
| Q2 24 | 24.5% | -697.4% |
净利率LARKRXRX
| Q1 26 | 27.0% | — | ||
| Q4 25 | 32.1% | -304.2% | ||
| Q3 25 | 27.1% | -3135.3% | ||
| Q2 25 | 25.4% | -894.2% | ||
| Q1 25 | 28.5% | -1373.3% | ||
| Q4 24 | 26.5% | -3935.5% | ||
| Q3 24 | 24.8% | -367.5% | ||
| Q2 24 | 20.5% | -676.6% |
每股收益（稀释后）LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | $0.66 | $-0.17 | ||
| Q3 25 | $0.85 | $-0.36 | ||
| Q2 25 | $0.75 | $-0.41 | ||
| Q1 25 | $0.81 | $-0.50 | ||
| Q4 24 | $0.47 | $-0.56 | ||
| Q3 24 | $0.68 | $-0.34 | ||
| Q2 24 | $0.52 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | — | $1.1B |
| 总资产 | $1.6B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LARKRXRX
| Q1 26 | $31.9M | — | ||
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M |
总债务LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M |
股东权益LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | $160.6M | $1.1B | ||
| Q3 25 | $155.7M | $1.0B | ||
| Q2 25 | $148.4M | $919.1M | ||
| Q1 25 | $142.7M | $933.9M | ||
| Q4 24 | $136.2M | $1.0B | ||
| Q3 24 | $139.7M | $524.6M | ||
| Q2 24 | $128.3M | $584.4M |
总资产LARKRXRX
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.6B | $726.5M | ||
| Q2 24 | $1.6B | $775.9M |
负债/权益比LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | $21.6M | $-46.1M | ||
| Q3 25 | $10.3M | $-117.4M | ||
| Q2 25 | $439.0K | $-76.4M | ||
| Q1 25 | $8.0M | $-132.0M | ||
| Q4 24 | $14.2M | $-115.4M | ||
| Q3 24 | $8.1M | $-59.2M | ||
| Q2 24 | $4.4M | $-82.2M |
自由现金流LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $-47.3M | ||
| Q3 25 | $10.1M | $-117.6M | ||
| Q2 25 | $354.0K | $-79.6M | ||
| Q1 25 | $8.0M | $-133.8M | ||
| Q4 24 | $11.9M | $-116.7M | ||
| Q3 24 | $7.8M | $-63.8M | ||
| Q2 24 | $3.8M | $-83.4M |
自由现金流率LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | 112.5% | -133.1% | ||
| Q3 25 | 55.4% | -2272.5% | ||
| Q2 25 | 2.0% | -413.9% | ||
| Q1 25 | 48.4% | -907.4% | ||
| Q4 24 | 75.6% | -2567.7% | ||
| Q3 24 | 49.3% | -244.6% | ||
| Q2 24 | 25.6% | -578.5% |
资本支出强度LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 3.5% | ||
| Q3 25 | 1.4% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 0.3% | 12.4% | ||
| Q4 24 | 14.7% | 28.6% | ||
| Q3 24 | 1.8% | 17.5% | ||
| Q2 24 | 4.2% | 8.2% |
现金转化率LARKRXRX
| Q1 26 | — | — | ||
| Q4 25 | 4.56× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 4.34× | — | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
